EMA committee recommends marketing approval for Novartis’ Scemblix to treat adults with newly diagnosed CML: Basel Monday, October 20, 2025, 11:00 Hrs [IST] Novartis announced t ...
Two physicians at the UNC Health system have been elected to the National Academy of Medicine, officials said Monday.
Baystreet.ca News Commentary – The convergence of advanced diagnostics and targeted therapeutics is reshaping cancer care, as ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the ...
Johnson & Johnson announces Tecvayli plus Darzalex Faspro combo regimen significantly improves PFS and overall survival versus standard of care: Raritan, New Jersey Saturday, Octo ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...
Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback